SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 201 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $4,160,000 | +49.2% | 331,982 | +85.8% | 0.01% | +25.0% |
| Q4 2020 | $2,788,000 | +194.1% | 178,630 | +70.5% | 0.00% | +100.0% |
| Q3 2019 | $948,000 | +207.8% | 104,771 | +224.8% | 0.00% | +100.0% |
| Q1 2019 | $308,000 | -76.4% | 32,254 | -71.6% | 0.00% | -66.7% |
| Q4 2018 | $1,305,000 | +0.9% | 113,661 | +48.9% | 0.00% | +50.0% |
| Q3 2018 | $1,294,000 | -55.5% | 76,317 | -62.7% | 0.00% | -66.7% |
| Q2 2018 | $2,905,000 | – | 204,550 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alexandria Capital, LLC | 968,505 | $12,135,000 | 1.23% |
| Golden State Equity Partners | 126,608 | $1,586,000 | 0.90% |
| McGuire Investment Group, LLC | 272,801 | $3,418,000 | 0.72% |
| Lombard Odier Asset Management (Switzerland) SA | 848,429 | $10,631,000 | 0.70% |
| Rhenman & Partners Asset Management AB | 765,000 | $9,585,000 | 0.67% |
| EMC Capital Management | 72,061 | $903,000 | 0.64% |
| WASATCH ADVISORS LP | 10,328,423 | $129,415,000 | 0.58% |
| Ceeto Capital Group, LLC | 74,000 | $927,000 | 0.45% |
| Fort Sheridan Advisors LLC | 75,945 | $952,000 | 0.38% |
| Vanguard Capital Wealth Advisors | 34,580 | $388,679,000 | 0.33% |